BridgeMD
New treatment option for Liver Metastasis Colon Cancer
Official title Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
ClinicalTrials.gov ID: NCT05314400
What this study is testing
- What it's testing
- After a patient is diagnosed with colon cancer, they receive a CT of the chest, abdomen, and pelvis to see if the cancer has spread (metastasized) to other parts of the body. A common site for the cancer to spread to is the liver.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female, 18 years of age or older
- Diagnosis of colorectal cancer, biopsy proven
- Prior imaging showing liver lesions that may be metastases
- Provision of signed and dated informed consent form
- Willingness to comply with study procedures and availability for the duration of the study
You likely can't join if
- Presence of implanted medical device or metallic object that is MR incompatible
- Baseline eGFR of \< 30 mL/min/1.73 m2
- Severe claustrophobia not relieved by oral anxiolytics
- Documented severe allergic-like reaction gadolinium-based contrast agent
- Weight greater than allowable on MRI table
- Pregnancy
See the full eligibility criteria
- Male or female, 18 years of age or older
- Diagnosis of colorectal cancer, biopsy proven
- Prior imaging showing liver lesions that may be metastases
- Provision of signed and dated informed consent form
- Willingness to comply with study procedures and availability for the duration of the study
- Able to tolerate MRI required by protocol
- Presence of implanted medical device or metallic object that is MR incompatible
- Baseline eGFR of \< 30 mL/min/1.73 m2
- Severe claustrophobia not relieved by oral anxiolytics
- Documented severe allergic-like reaction gadolinium-based contrast agent
- Weight greater than allowable on MRI table
- Pregnancy
- Diffuse liver metastases, i.e. definitively unresectable
- Severe liver dysfunction, ALBI grade 3
The study team makes the final eligibility decision.
Where it's taking place
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.